Varian Medical Systems
A medical-technology brand specializing in radiation oncology equipment, software, proton therapy, and radiosurgery.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Varian Medical Systems is an American medical-technology brand focused on the diagnosis, planning, delivery, and management of cancer treatment. Its core portfolio includes medical linear accelerators, radiosurgery systems, proton-therapy equipment, brachytherapy products, treatment-planning applications, oncology information systems, and software used by hospitals, cancer centers, radiotherapy departments, and medical oncology practices. The company is particularly associated with external-beam radiation therapy, in which high-energy radiation is precisely directed at tumors while treatment-planning and image-guidance technologies help clinicians manage dose distribution and patient positioning. The business traces its technical heritage to Varian Associates, founded in 1948 by Russell H. Varian, Sigurd F. Varian, William Webster Hansen, and Edward Ginzton. Varian Associates initially commercialized microwave technology, including the klystron, and later developed businesses in semiconductors, vacuum equipment, and medical devices. On April 2, 1999, the medical-device activities were separated into Varian Medical Systems, while other divisions became separate companies including Varian Semiconductor and Varian, Inc. The newly independent medical company built its identity around radiation oncology and expanded through internal development, acquisitions, and international installations. Varian's product strategy combined treatment hardware with increasingly integrated software and clinical workflow tools. Its linear-accelerator portfolio included systems designed for conventional radiotherapy, image-guided treatment, stereotactic radiosurgery, and highly automated workflows. TrueBeam became a major platform for image-guided radiotherapy and radiosurgery, while the EDGE suite was positioned for stereotactic procedures. In 2017, Varian introduced Halcyon, a system designed to simplify and automate elements of radiotherapy delivery and daily machine checks. The company also developed ProBeam, a pencil-beam-scanning proton-therapy platform using intensity-modulated proton therapy, and expanded into adaptive radiotherapy and artificial-intelligence-supported treatment through Ethos Therapy, announced in 2019. Alongside equipment, Varian supplied software for treatment planning, clinical information management, oncology workflows, and the operation of radiotherapy centers and medical oncology practices. Acquisitions broadened those capabilities, including purchases involving imaging, treatment-planning, oncology information, and clinical workflow technologies. In 2017, the X-ray imaging business was separated into Varex Imaging Corporation. In 2018, Varian announced the acquisition of Sirtex Medical, adding the SIR-Spheres microspheres business and a form of liver-directed cancer treatment to its portfolio. In 2019, it acquired CyberHeart, whose intellectual property related to cardiac radioablation and radiosurgical applications in cardiovascular disease. Siemens Healthineers announced in August 2020 that it intended to acquire Varian in an all-stock transaction valued at approximately $16.4 billion. The transaction closed in April 2021. Following the acquisition, Varian ceased to operate as an independent publicly traded company, while the Varian name, headquarters, workforce, products, and clinical focus were retained within Siemens Healthineers. The brand therefore remains active as a specialist oncology-technology business, but its former standalone listing and corporate independence ended with the merger.
History
Varian Medical Systems emerged from the medical-device activities of Varian Associates, a technology company founded in 1948 by Russell H. Varian, Sigurd F. Varian, William Webster Hansen, and Edward Ginzton. Varian Associates was established to commercialize microwave technologies, particularly the klystron, and subsequently developed businesses spanning semiconductor equipment, vacuum technology, and medical devices. By the late twentieth century, the medical business had become sufficiently distinct to support a separate corporate identity. On April 2, 1999, Varian Associates separated its principal businesses. The medical-device operation became Varian Medical Systems, while other activities were organized into separate companies. Varian Medical Systems established its headquarters in Palo Alto, California, and concentrated on radiation oncology. Its principal technologies included megavoltage linear accelerators, multileaf collimators, treatment-planning systems, image guidance, radiosurgery, brachytherapy, and software for managing cancer-care operations. The company grew through a combination of product development and acquisitions. It acquired or integrated businesses associated with imaging, treatment planning, oncology information, and clinical workflow, including Pan-Pacific Enterprises, ACCEL Instruments, Bio-Imaging Research, Sigma Micro Informatique Conseil, Argus Software, Dosetek, Velocity Medical Solutions, and MeVis Medical Solutions. On January 30, 2017, Varian completed the spin-off of Varex Imaging Corporation, which became an independent manufacturer of X-ray imaging products. Varian's hardware portfolio included the TrueBeam radiotherapy platform and the EDGE radiosurgery suite. EDGE was launched in 2012 and was adopted by early cancer-center users including the Champalimaud Foundation in Lisbon and Henry Ford Health System in Detroit. In 2017, Varian launched Halcyon, a linear-accelerator platform intended to improve treatment-room workflow through automation, a dual-layer multileaf collimator, automated beam changes, and automated daily performance checks. The company also marketed ProBeam, a proton-therapy system using pencil-beam scanning and intensity-modulated proton therapy. Proton-related activities included treatment-delivery equipment and software for treatment planning and radiology information management. Varian continued to broaden its clinical scope. In January 2018, it announced the acquisition of Sirtex Medical for approximately $1.3 billion, adding SIR-Spheres microspheres and liver-directed oncology treatment. In 2019, it acquired CyberHeart, a privately held company whose intellectual property covered radiation-based cardiac ablation and related radiosurgical applications. In September 2019, at the annual meeting of the American Society for Radiation Oncology, Varian announced Ethos Therapy, an artificial-intelligence-supported platform designed to make adaptive radiotherapy more practical within routine treatment workflows. The company also faced legal disputes. In 1999, it sued a former employee for defamation over online criticism. The case, Varian v. Delfino, generated a California Supreme Court decision concerning whether proceedings could continue while an order denying an anti-SLAPP motion was under appeal; the dispute was ultimately settled. In 2012, the University of Pittsburgh prevailed in a medical-patent infringement action, and a federal judge awarded attorney fees, costs, and doubled damages totaling $73.6 million. In August 2020, Siemens Healthineers announced its plan to acquire Varian in an all-stock transaction valued at approximately $16.4 billion. The transaction closed in April 2021. Varian consequently stopped being an independent listed company, but Siemens Healthineers retained the Varian brand, business operations, headquarters, employees, and oncology product portfolio. The brand now functions as a Siemens Healthineers oncology business rather than as a separately traded corporation.
- 2021
Acquisition by Siemens Healthineers closes
[1]The merger closes in April, ending Varian's independent public-company status.
- 2020
Siemens Healthineers announces acquisition plan
[1]Siemens Healthineers announces a planned all-stock acquisition of Varian valued at approximately $16.4 billion.
- 2019
Ethos Therapy is announced
[1]Varian announces an AI-enabled adaptive-radiotherapy platform at the ASTRO annual meeting.
- 2018
Sirtex Medical acquisition announced
[1]Varian announces the acquisition of Sirtex Medical and its SIR-Spheres liver-directed oncology treatment.
- 2017
Varex Imaging is spun off
[1]Varian completes the separation of its X-ray imaging business into Varex Imaging Corporation.
- 2017
Halcyon is introduced
[1]Varian launches Halcyon, an automated radiotherapy system designed to simplify clinical operation and improve treatment workflow.
- 2012
EDGE radiosurgery suite launches
[1]Varian launches EDGE for stereotactic radiosurgery and related precision radiation procedures.
- 1999
Medical business becomes Varian Medical Systems
[1]The medical-device activities of Varian Associates are separated into Varian Medical Systems on April 2.
- 1948
Varian Associates is founded
[1]Russell H. Varian, Sigurd F. Varian, William Webster Hansen, and Edward Ginzton establish Varian Associates to commercialize microwave and electromagnetic technologies.
Products and positioning
A high-end, integrated oncology-technology provider combining radiation-treatment hardware, precision delivery, proton therapy, automation, and clinical software.
Radiotherapy and radiosurgery system
TrueBeam
TrueBeam is Varian's image-guided radiotherapy platform for delivering external-beam radiation and stereotactic treatments. It combines a medical linear accelerator with imaging, patient-positioning, and treatment-delivery capabilities intended to support precision radiation procedures across a range of cancer indications.
Radiosurgery system · 2012
EDGE
EDGE is a radiosurgery suite introduced in 2012 for highly focused radiation treatments. It is designed for stereotactic procedures that require precise targeting and image guidance, and was deployed by early cancer-center users in Europe and the United States.
Linear accelerator · 2017
Halcyon
Halcyon is a radiotherapy system launched in 2017 with an emphasis on automation and streamlined clinical workflow. Its design includes a dual-layer multileaf collimator, automated treatment-beam changes, and automated daily machine-performance checks intended to reduce routine operational burden.
Proton-therapy system
ProBeam
ProBeam is Varian's proton-therapy platform. It uses pencil-beam scanning and intensity-modulated proton therapy to shape proton dose delivery, and is supported by treatment-planning and information-system software for proton-treatment centers.
Adaptive radiotherapy platform · 2019
Ethos Therapy
Ethos Therapy is an AI-supported radiotherapy platform announced in 2019. It is designed to support adaptive treatment by helping clinicians adjust plans to a patient's anatomy during the course of care, with an emphasis on integrating setup, planning, and treatment delivery into a short clinical workflow.
Brand decisions
2020
Agree to be acquired by Siemens HealthineersM&ABackground
Varian and Siemens Healthineers pursued a combination to create a broader cancer-care and medical-technology platform.
Action taken
The companies announced an all-stock acquisition agreement in August 2020.
Aftermath
The transaction closed in April 2021, and Varian continued as a Siemens Healthineers oncology business.
Announced transaction value. $16.4 billion (August 2020)
2019
Introduce Ethos TherapyProduct launchBackground
Radiotherapy providers were seeking more adaptive, efficient, and software-coordinated treatment workflows.
Action taken
Varian announced Ethos Therapy, an AI-driven platform intended to support adaptive radiotherapy.
Aftermath
The announcement strengthened Varian's positioning in software-enabled and adaptive cancer treatment.
2018
Acquire Sirtex MedicalM&ABackground
Varian sought to broaden its cancer-treatment portfolio beyond radiation-delivery equipment.
Action taken
The company announced the acquisition of Sirtex Medical and its SIR-Spheres microspheres business.
Aftermath
The transaction expanded Varian's oncology offering into liver-directed cancer treatment.
Announced transaction value. $1.3 billion (2018)
2017
Separate the X-ray imaging business into Varex ImagingM&ABackground
Varian's X-ray imaging activities were distinct from its oncology-treatment business and were prepared for separation.
Action taken
Varian completed the spin-off of Varex Imaging Corporation on January 30.
Aftermath
Varex became an independent manufacturer of X-ray imaging products, while Varian concentrated more clearly on oncology technology.
Recent events
Siemens Healthineers completes acquisition of Varian[3]
Reported:
Siemens Healthineers announced that it completed its acquisition of Varian Medical Systems on April 15, 2021.
Siemens Healthineers announces acquisition of Varian[4]
Reported:
Siemens Healthineers confirmed that it would acquire Varian Medical Systems in an all-cash transaction valued at $16.4 billion on a fully diluted basis.
Sources7 sources
- 1Varian Medical Systemsen.wikipedia.org
- 2Varian official websitevarian.com
- 3Siemens Healthineers完成对Varian的收购itnonline.com
- 4西门子医疗宣布收购瓦里安tech.sina.com.cn
- 5【深度】西门子医疗164亿美元收购瓦里安，全球医疗器械公司迎来变局？finance.sina.com.cn
- 6西门子164亿美元收购瓦里安，创今年医疗领域最大收购案-钛媒体官方网站tmtpost.com
- 7Varian Acquired by Siemens Healthineers for $16 Billionlawstreetmedia.com
Cite this profile: Cite the canonical profile. /brand-wiki/varian-medical-systems · Editorial policy · How profiles are compiled